A clinical-stage biotechnology company focused on developing abuse-deterrent opioid pain medications using proprietary prodrug and overdose-protection technologies. Its pipeline centers on tamper-resistant formulations designed to reduce the risk of opioid misuse while maintaining analgesic effectiv...
No congressional trades have been disclosed for Ensysce Biosciences, Inc. (ENSC) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.